Clinical trial
Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment…
NCT00373815 · University Hospital Tuebingen, Other · Terminated
Key facts
| NCT number | NCT00373815 |
|---|---|
| Title | Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease |
| Official title | A Phase I Dose Escalation Study With Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Acute GVHD After Allogeneic Hematopoietic Stem Cell Transplantation |
| Lead sponsor | University Hospital Tuebingen, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease |
| Intervention type | Drug |
| Interventions | Everolimus |
| Enrollment | 10 |
| Start date | Sep 1, 2006 |
| Completion | Oct 1, 2009 |
| First posted | Sep 8, 2006 |
| Last update posted | May 29, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: